Stumpo R J, Pullan L M, Salama A I
Department of Pharmacology, ICI Pharmaceuticals Group, ICI Americas Inc., Wilmington, DE 19897.
Eur J Pharmacol. 1991 Feb 25;206(2):155-8. doi: 10.1016/0922-4106(91)90024-c.
omega-Conotoxin GVIA (omega-CT) has been reported to block calcium currents at the L- and N-type calcium channels. In neuronal membranes omega-CT, and the aminoglycoside antibiotic neomycin, have been shown to inhibit [125I]omega-CT binding, presumably acting at the N-type calcium channel. We demonstrate here that the concentration curve for neomycin sulfate inhibition of [125I]omega-CT binding is shifted to the right by GTP analogues or fluoride, increasing the IC50 for neomycin. [125I]omega-CT binding is unaffected by these agents and in competition studies the potency of omega-CT, Ca2+, or La3+ is not modulated by GTP analogues or fluoride. These results indicate that the inhibition of [125I]omega-CT binding by neomycin may be mediated by a GTP binding protein.
据报道,ω-芋螺毒素GVIA(ω-CT)可阻断L型和N型钙通道的钙电流。在神经元膜中,ω-CT和氨基糖苷类抗生素新霉素已被证明可抑制[125I]ω-CT结合,推测其作用于N型钙通道。我们在此证明,硫酸新霉素对[125I]ω-CT结合的抑制浓度曲线会被GTP类似物或氟化物向右移动,从而增加新霉素的半数抑制浓度(IC50)。[125I]ω-CT结合不受这些试剂影响,并且在竞争研究中,ω-CT、Ca2+或La3+的效力不受GTP类似物或氟化物调节。这些结果表明,新霉素对[125I]ω-CT结合的抑制可能由一种GTP结合蛋白介导。